Evidence map›Paper›PMID 32738466›Full record

ReviewThe American journal of emergency medicine2020

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis.

Brandon Michael Henry, Gaurav Aggarwal, Johnny Wong, Stefanie Benoit, Jens Vikse, Mario Plebani, Giuseppe Lippi

Open access · greenAbstract readReview
In one paragraph

Review in The American journal of emergency medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 322 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
322citing papers in PubMed, 3 pooled it
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

322 citing papers in PubMed, 3 syntheses or guidelines pooled it, 628 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. InflawellInflammopharmacology · 2022
    Trial
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

262 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Brandon Michael HenryCardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Electronic address: Brandon.henry@cchmc.org.
Gaurav AggarwalDepartment of Medicine, Jersey City Medical Center, Jersey City, NJ, USA.
Johnny WongCollege of Medicine, SUNY Downstate Health Sciences University, New York, USA.
Stefanie BenoitDivision of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, OH, USA; Department of Pediatrics, College of Medicine, University of Cincinnati, OH, USA.
Jens VikseDepartment of Clinical immunology, Stavanger University Hospital, Stavanger, Norway.
Mario PlebaniDepartment of Lab Medicine, University Hospital, Padova, Italy.
Giuseppe LippiSection of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
Cincinnati Children's Hospital Medical Center · USJersey City Medical Center · USStavanger University Hospital · NOSUNY Downstate Health Sciences University · USUniversity of Padua · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) infection has now reached a pandemic state, affecting more than a million patients worldwide. Predictors of disease outcomes in these patients need to be urgently assessed to decrease morbidity and societal burden. Lactate dehydrogenase (LDH) has been associated with worse outcomes in patients with viral infections. In this pooled analysis of 9 published studies (n = 1532 COVID-19 patients), we evaluated the association between elevated LDH levels measured at earliest time point in hospitalization and disease outcomes in patients with COVID-19. Elevated LDH levels were associated with a ~6-fold increase in odds of developing severe disease and a ~16-fold increase in odds of mortality in patients with COVID-19. Larger studies are needed to confirm these findings.

Indexed as

BetacoronavirusPandemicsBiomarkersCoronavirus InfectionsCOVID-19C-Reactive ProteinGlobal HealthHumansL-Lactate DehydrogenasePneumonia, ViralSARS-CoV-2Severity of Illness IndexSurvival RateBiomarkersC-Reactive ProteinL-Lactate DehydrogenaseCoronavirusCOVID-19Lactate dehydrogenase

Identifiers

PMID32738466
PMCPMC7251362
OpenAlexW3028902173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.